This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (71)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Hypersensitivity  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

This article reports patch-testing results from July 1, 1996, to June 30, 1998. Over 3400 patients with suspected allergic contact dermatitis were evaluated and then patch tested by 12 North American Contact Dermatitis Group dermatologists with a screening series of 50 allergens purchased from Chemotechnique Diagnostics AB (Malmö, Sweden). The patients were patch tested using a standardized technique as outlined previously¹ with Finn chambers (Epitest Ltd Oy, Tuusula, Finland) on Scanpor tape (Norgesplaster Aksjeselskap, Vennesia, Norway). The patches remained in place for 48 hours, and test sites were evaluated twice, initially at 48 to 72 hours and again between 72 and 168 hours after initial placement. A positive allergic patch test result was generally interpreted to be a 1+, 2+, or 3+ reaction manifested by erythematous papules, vesicles, or a spreading reaction with crust and ulceration.^1-2 The relevance of the patch-test reactions were determined in combination with the patient's history . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Thoughts on Implants and Contact Allergy
Bruze
Arch Dermatol 2008;144:1042-1044.
FULL TEXT  

Changing Trends and Allergens in the Patch Test Standard Series: A Mayo Clinic 5-Year Retrospective Review, January 1, 2001, Through December 31, 2005
Davis et al.
Arch Dermatol 2008;144:67-72.
ABSTRACT | FULL TEXT  

Allergic Contact Dermatitis: Another Adverse Effect of Over-the-counter Topical Hydrocortisone
Watsky and Warshaw
Arch Dermatol 2007;143:1217-1217.
FULL TEXT  

Annual Review of Cosmetic Ingredient Safety Assessments--2004/2005
International Journal of Toxicology 2006;25:1-89.
FULL TEXT  

Annual Review of Cosmetic Ingredient Safety Assessments--2002/2003
International Journal of Toxicology 2005;24:1-2.
FULL TEXT  

Direct and indirect restorative materials
ADA COUNCIL ON SCIENTIFIC AFFAIRS
Journal of the American Dental Association 2003;134:463-472.
ABSTRACT | FULL TEXT  

Delayed-Type Hypersensitivity to Lidocaine
Mackley et al.
Arch Dermatol 2003;139:343-346.
ABSTRACT | FULL TEXT  

Imidazolidinyl Urea
International Journal of Toxicology 2003;22:17-19.
 

Cellular Phone Dermatitis
Seishima et al.
Arch Dermatol 2002;138:272-273.
FULL TEXT